Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes
{{output}}
Recent clinical trials, investigating type 1 diabetes (T1D), have focused mainly on newly diagnosed individuals who have developed diabetes. We need to continue our efforts to understand disease processes and to rationally design interventions that will be saf... ...
